Ciliary Body Excision in Secondary Glaucoma: A Fifteen-Year Follow-Up

2015 ◽  
pp. 138-139
Author(s):  
U. Demeler
Keyword(s):  
Ciliary Body ◽  
Secondary Glaucoma

scholarly journals A 2-year prospective multicenter study of ultrasound cyclo plasty for glaucoma

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Giuseppe Giannaccare ◽  
Marco Pellegrini ◽  
Federico Bernabei ◽  
Lara Urbini ◽  
Fulvio Bergamini ◽  
...  
Keyword(s):  
Ciliary Body ◽  
Glaucoma Surgery ◽  
Secondary Glaucoma ◽  
Eye Drops ◽  
Safe Procedure ◽  
Efficacy And Safety ◽  
Prospective Multicenter Study ◽  
Definition Of

AbstractUltrasound cyclo plasty (UCP) is a recently developed surgical technique for glaucoma allowing a selective and controlled coagulation of the ciliary body. We herein investigated the long-term efficacy and safety of UCP for the treatment of glaucoma. This prospective study included patients with primary and secondary glaucoma. All surgeries were performed using the EyeOP1 device (Eye Tech Care, Rillieux-la-Pape, France). Sixty-six patients were included, and 60 completed regularly the 2-year follow-up. Preoperative IOP was 28.5 ± 9.6 mmHg and significantly decreased to 17.0 ± 5.4 at 2 years (p < 0.001). The daily number of both hypotensive eye drops and acetazolamide tablets decreased significantly (respectively, from 2.6 ± 1.1 to 1.7 ± 1.2 and from 0.7 ± 0.8 to 0.2 ± 0.5; both p < 0.001). At 2 years, 68.1% of patients met the definition of qualified success (IOP < 21 mmHg regardless of glaucoma medications) and 10.3% of patients met the definition of complete success (IOP < 21 mmHg without glaucoma medications). No major intra- or postoperative complications occurred; however, 15 eyes required additional glaucoma surgery. These results suggest that UCP is an effective and safe procedure to reduce IOP in glaucoma patients through a 2-year follow-up period.

The girl with the eyeball tattoo—what the ophthalmologist may expect? Case report and a review of literature

2018 ◽  
Vol 29 (5) ◽  
pp. NP1-NP4 ◽  
Author(s):  
Katarzyna Tubek ◽  
Tomasz Berus ◽  
Robert Leszek
Keyword(s):  
Ocular Inflammation ◽  
Secondary Glaucoma ◽  
Bulbar Conjunctiva ◽  
Review Of Literature ◽  
Eye Pain ◽  
Eyelid Edema ◽  
Anterior Lens Capsule ◽  
Contralateral Eye ◽  
First Time

Introduction: We report a case of patient who underwent bilateral eyeball tattoo procedure for cosmetic purpose complicated with intraocular dye injection which led to ocular inflammation, secondary glaucoma, and cataract. Case description: A 21-year-old female presented to emergency department with severe right eye pain and photophobia 21 days after conjunctival tattooing procedure. Slit-lamp examination revealed right-sided eyelid edema and black deposits of tattoo ink under the bulbar conjunctiva. Dye deposits were also present in anterior chamber, covering corneal endothelium, iris and anterior lens’ capsule. Ocular inflammation and secondary glaucoma were diagnosed. The patient underwent surgical treatment to control ocular inflammation. Intraocular pressure remained stable after Nd:YAG iridotomy and on topical drugs. Moreover, during the follow-up, in contralateral eye, we observed “conjunctival lumps”—local hypersensitivity reaction to the dye, which were asymptomatic to the patient. Conclusion: Eyeball tattooing complications are new challenges that ophthalmologist may have to face nowadays. We also reviewed for the first time possible complications of eyeball tattooing described in available literature.

Outcomes of micropulse transscleral cyclophotocoagulation in primary open-angle glaucoma, pseudoexfoliation glaucoma, and secondary glaucoma

2020 ◽  
pp. 112067212091423 ◽  
Author(s):  
Oya Tekeli ◽  
Helin Ceren Köse
Keyword(s):  
Intraocular Pressure ◽  
Primary Open Angle Glaucoma ◽  
Open Angle Glaucoma ◽  
Secondary Glaucoma ◽  
Open Angle ◽  
Pseudoexfoliation Glaucoma ◽  
Transscleral Cyclophotocoagulation ◽  
The Mean ◽  
Glaucoma Group

Purpose: The aim of this study is to compare the outcomes of micropulse transscleral cyclophotocoagulation between primary open-angle glaucoma, pseudoexfoliation glaucoma, and other types of secondary glaucoma. Methods: Outcomes of 96 consecutive patients with refractory, end-stage glaucoma treated with micropulse transscleral cyclophotocoagulation were retrospectively reviewed. Follow-up examinations were performed on a regular basis until 12 months postoperatively. Surgical successes were defined as maintaining intraocular pressure ⩽18 mmHg and ⩾20% reduction in intraocular pressure (criteria A), ⩽15 mmHg intraocular pressure and ⩾25% reduction in intraocular pressure (criteria B), and ⩽12 mmHg intraocular pressure and ⩾30% reduction in intraocular pressure from baseline (criteria C). Results: Ninety-six eyes of 96 patients (50 (52%) females, 46 (48%) males) were included. Among all eyes, 32 were primary open-angle glaucoma, 30 were pseudoexfoliation glaucoma, and 34 were other types of secondary glaucoma. The mean age was 59.37 ± 11.45 (range: 20–91) years. The mean follow-up period was 14.2 ± 3.9 (range: 12–16) months. At 12 months, the success rates of primary open-angle glaucoma, pseudoexfoliation glaucoma, and secondary glaucoma group were 68.75%, 66.6%, and 64.7% (p = 0.185) for criteria A; 56.25%, 53.3%, and 50% (p = 0.153) for criteria B; and 43.75%, 43.3%, and 38.2% (p = 0.146) for criteria C. Four patients (12.5%) in primary open-angle glaucoma group, 5 patients (16.6%) in pseudoexfoliation glaucoma group, and 14 (41.2%) patients in other secondary glaucoma group required reoperation during the follow-up (p < 0.05). Conclusion: Micropulse transscleral cyclophotocoagulation is an equally effective method of lowering intraocular pressure in patients with primary open-angle glaucoma, pseudoexfoliation glaucoma, and other types of secondary glaucoma. The rate of reoperation was higher in refractory secondary glaucoma patients.

Pars plana Ex-Press mini shunt for management of persistent glaucoma in vitrectomized eyes: A novel technique

2020 ◽  
Vol 30 (5) ◽  
pp. 1179-1184 ◽  
Author(s):  
Abdussalam Abdullatif ◽  
Heba El-Saied
Keyword(s):  
Intraocular Pressure ◽  
Silicone Oil ◽  
Case Series ◽  
Ultrasound Biomicroscopy ◽  
Secondary Glaucoma ◽  
Antiglaucoma Medication ◽  
Novel Approach ◽  
Pars Plana ◽  
Secondary Refractory

Purpose: To evaluate the safety and efficacy of a novel approach to implant Ex-Press mini shunt via the pars plana under a scleral flap in pseudophakic or aphakic, vitrectomized patients with secondary refractory glaucoma. Methods: A prospective interventional case series of three patients with secondary glaucoma after pars plana vitrectomy. Intraocular pressure was not controlled by silicone oil removal, if the patient was siliconized, nor the maximum medical treatment. Ex-Press mini shunt via the pars plana was implanted. We evaluated the control of intraocular pressure and the development of intraoperative and postoperative complications. Results: During 1-year follow-up, control of intraocular pressure was achieved; 14, 15, and 15 mmHg at the 3 months, and 15, 15, and 16 mmHg at the 6 months in our three cases without antiglaucoma treatment and 16, 16, and 18 with single antiglaucoma medication at 1 year. Blebs were posterior and diffuse. No complications were encountered intraoperatively or postoperatively. Ultrasound biomicroscopy showed suprachoroidal posterior lake of fluid as an additional filtration route without any choroidal or retinal complication. Conclusion: Implantation of Ex-Press mini shunt via the pars plana in aphakic or pseudophakic, vitrectomized eyes is a promising, safe, and effective technique in patients with secondary glaucoma.

Trabeculectomy in an unsuspected extramedullary iris–ciliary body plasmacytoma

2020 ◽  
pp. 112067212092022
Author(s):  
Harathy Selvan ◽  
Seema Kashyap ◽  
Seema Sen ◽  
Bhavna Chawla ◽  
Neiwete Lomi ◽  
...  
Keyword(s):  
Ciliary Body ◽  
Histopathological Examination ◽  
Neovascular Glaucoma ◽  
Ultrasound Biomicroscopy ◽  
Extramedullary Plasmacytoma ◽  
Plasma Cell Dyscrasia ◽  
Post Operative Period ◽  
Bleb Failure ◽  
Disease Free

Extramedullary plasmacytoma of the iris and ciliary body is extremely rare. We present a case which was misdiagnosed as granulomatous uveitis with neovascular glaucoma, and underwent a trabeculectomy with mitomycin-c along with iris biopsy. The post-operative period showed early bleb failure and catastrophic growth of the suspected mass. Histopathological examination revealed a diagnosis iris plasmacytoma. Subsequent ultrasound biomicroscopy showed involvement of the iris and ciliary body. A prompt systemic workup was done, and an associated systemic plasma cell dyscrasia was ruled out. The affected eye was enucleated, and the patient remains disease free at the end of 3-year follow-up.

scholarly journals The Masquerades of a Childhood Ciliary Body Medulloepithelioma: A Case of Chronic Uveitis, Cataract, and Secondary Glaucoma

2012 ◽  
Vol 2012 ◽  
pp. 1-3 ◽  
Author(s):  
Jocelyn Chua ◽  
Wisam J. Muen ◽  
Ashwin Reddy ◽  
John Brookes
Keyword(s):  
Anterior Chamber ◽  
Ciliary Body ◽  
Ocular Trauma ◽  
Delayed Diagnosis ◽  
Secondary Glaucoma ◽  
Secondary Effects ◽  
Tumor Seeding ◽  
Chronic Uveitis ◽  
Aqueous Shunt ◽  
Blunt Ocular Trauma

Ciliary body medulloepitheliomas in childhood often masquerade other intraocular conditions due to its insidious nature as well as its secondary effects on proximal intraocular tissues in the anterior chamber. We report a case where a ciliary body medulloepithelioma in a two-year-old boy presents with chronic uveitis, cataract, and an uncontrolled secondary glaucoma after an innocuous blunt ocular trauma. The diagnosis was only made after the occurrence of a ciliary body mass. We discuss the clinical features of ciliary body medulloepitheliomas, the implications of a delayed diagnosis and treatment as well as the concern of periorbital tumor seeding with the use of an aqueous shunt implant in this case.

scholarly journals Eye sarcoidosis. Literature review

2012 ◽  
Vol 93 (6) ◽  
pp. 948-953 ◽  
Author(s):  
A S Tezeva ◽  
A N Samoylov
Keyword(s):  
Ciliary Body ◽  
Treatment Options ◽  
Giant Cells ◽  
Acute Stage ◽  
Secondary Glaucoma ◽  
Unknown Etiology ◽  
Review Of The Literature ◽  
Target Organs ◽  
Eye Involvement ◽  
Epithelium Cells

A review of the literature devoted to eye sarcoidosis is presented. Sarcoidosis is a systemic granulomatous disease of unknown etiology, with a pathognomonic feature of non-caseous granuloma formed mainly by epithelium cells and single Langhans giant cells. Sarcoidosis has many synonyms: Besnier-Boeck-Schaumann disease, benign Schaumann’s granulomatosis, nodular reticular disease. Primary targets of sarcoidosis are lungs, intrathoracic lymph nodes, eyes and skin. During the last years eye sarcoidosis is registered more frequently, that is probably associated with better diagnosis. The frequency of the eye involvement in patients with sarcoidosis, according to different authors, is 5-69% (3rd or 4th among all the target organs involved). The eye manifestations of sarcoidosis are multiple with the uvea most frequently affected, especially iris and ciliary body. The involvement of the back of the eye includes granulomatous uveitis, vitreitis, periphlebitis. It is worth noticing that only minor non-granulomatous precipitates can be found in the acute stage of the disease. In case of chronic inflammatory process, precipitates become granulomatous. The treatment can influence both precipitates’ size and shape. In case of termination of the inflammation, precipitates are undergoing a complete resorption or decrease in size, become pigmented of transparent («precipitate shades»). The feature of sarcoidosis is the tendency to comissure formation, the pupil is hardly dilated by medicines, leading to the secondary glaucoma. Conjunctiva, extraocular muscles, retroocular tissues, lacrimal gland can be involved, as well as the optic nerve, chiasma, leading to meningovascular infiltrates formation. When diagnosed, a complex treatment with topic, symptomatic drugs and the drugs with the systemic action is used. The search of new effective treatment options is still ongoing.

scholarly journals Long-term Follow-up of 14 Eyes With Bilateral and Multiple Ciliary Body Cysts: Prognosis of this Rare Entity

2020 ◽  
Vol 30 (1) ◽  
pp. e13-e17
Author(s):  
Juliette Hugo ◽  
Charles Feumi ◽  
Adèle Morin ◽  
Michelle Nguyen ◽  
Yves Lachkar
Keyword(s):  
Ciliary Body ◽  
Rare Entity ◽  
Long Term Follow Up

scholarly journals Case Report with Review of the Literature: Uveal Melanoma in a Patient with Carney Complex – Another Rare Component of the Syndrome?

2020 ◽  
Vol 6 (5) ◽  
pp. 311-317
Author(s):  
Diva R. Salomão ◽  
Cristiane M. Ida ◽  
Patricia T. Greipp ◽  
J. Aidan Carney
Keyword(s):  
Case Report ◽  
Uveal Melanoma ◽  
Ciliary Body ◽  
Carney Complex ◽  
Review Of The Literature ◽  
Poor Vision ◽  
Monosomy 3 ◽  
Molecular Studies ◽  
Complex Genome

A 74-year-old woman with Carney complex (CNC) and complaints of poor vision was found, on ophthalmic examination, to have a pigmented tumor involving the peripheral choroid and ciliary body in her right eye. The eye was enucleated and showed a ciliochoroidal melanoma with marked pleomorphism. The tumor did not recur or metastasize after almost 10 years of follow-up, and the patient died of unrelated causes. Molecular studies revealed a complex genome with multiple whole-chromosome losses including monosomy of chromosomes 1, 2 (including loss of CNC2at 2p16), 14, 17 (including loss of a copy of PRAKA1 at 17q24.2), 18, 19, 21, 22, and X. No monosomy 3 was observed. This is only the second case of uveal melanoma in a patient with CNC, raising the possibility that this might represent a rare component of this syndrome.

Sign in / Sign up

Export Citation Format

Share Document